l.lundgren
TL2 · Bilbao
Contributes reviews on supplier material. Based in Bilbao.
Joined 11 July 2025 · last posted 6d
82 posts, newest first. Showing up to 150.
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #44 · Research Methods › N-of-1 designs · 22 Jul 2026 · 23 likes On post #42 — agreed on the reasoning, with one qualification. The reason Washout keeps being re-asked is that the answer is conditional and people quote it without the…
-
Why pulsatile secretion matters for interpreting secretagogue claims Replied, post #8 · Compounds › Secretagogues & GH axis · 20 Jul 2026 · 10 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #40 · Compounds › Repair & healing peptides · 19 Jul 2026 · 8 likes Everything in post #38 holds. The case it does not cover is the one I have. An update on my earlier absence of controlled human data post: the pattern held for another…
-
Private prescribing in the UK: what is actually involved Replied, post #64 · Regional › UK & Ireland · 14 Jul 2026 · 0 likes Everything in post #62 holds. The case it does not cover is the one I have. If someone has run private prescribing properly I would rather read that than my own…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #46 · Practice › Side effects · 12 Jul 2026 · 9 likes Where the Muscle cramps discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Designing a personal experiment that could change your mind — one year on Replied, post #74 · Research Methods › N-of-1 designs · 12 Jul 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
What is genuinely unknown about long-term amylin agonism Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2026 · 31 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
-
Follow-up: Reading an interaction checker output critically Replied, post #34 · Practice › Interactions · 6 Jul 2026 · 33 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #38 · Research Methods › Statistics · 6 Jul 2026 · 17 likes Adding the measurement that post #36 says would settle it. Survivorship in a self-reporting population biases every aggregate produced from it, and the bias is in the…
-
How much context is too much context in a first post? Replied, post #11 · Start Here › How to Ask · 5 Jul 2026 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Asking a follow-up: new topic or new reply? Replied, post #33 · Start Here › How to Ask · 1 Jul 2026 · 0 likes I had written a reply contradicting post #31 and deleted it. Here is what survived. Context that matters: compound, how long in, current dose, relevant history. Context…
-
Request: tag synonyms surfaced in search Replied, post #9 · Meta › Feature requests · 30 Jun 2026 · 4 likes Two claims get bundled together under tag synonyms surfaced in search and they need separating. The descriptive one — this is what was observed — is usually well…
-
Reading a home test result without over-claiming Replied, post #95 · Analytics › Home & field testing · 26 Jun 2026 · 3 likes Weighing vials against declared fill is the most underrated home check available. It needs a balance with adequate resolution and it catches fill problems that no…
-
Second pass at: The storage lookup and where its data comes from Replied, post #36 · Data & Tools › Calculators · 25 Jun 2026 · 7 likes What I can speak to on storage lookup is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #33 · Documentation › Doc review · 24 Jun 2026 · 0 likes The arithmetic in post #31 is right; the assumption feeding it is the part to check. A review date is a commitment rather than a formality, and a shorter cycle for a…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #33 · Access › Insurance & coverage · 22 Jun 2026 · 30 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. The useful distinction on Prior authorisation is between what was…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #91 · Evidence › Journal club · 19 Jun 2026 · 0 likes Careful with the language on indirect comparison. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Journal club: LEADER as the historical anchor Replied, post #91 · Evidence › Journal club · 18 Jun 2026 · 14 likes Understood, and I withdraw the assumption I opened with.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #35 · Evidence › Journal club · 14 Jun 2026 · 2 likes I would call the community position on SURMOUNT-OSA likely rather than established, and I would be comfortable defending that hedge.
-
Racemisation and why it is invisible to a mass measurement Replied, post #82 · Analytics › Impurities & related substances · 13 Jun 2026 · 15 likes Racemisation has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Batch numbers that do not match the vial label — what changed since Replied, post #32 · Sourcing › Red flags · 8 Jun 2026 · 0 likes Building on post #29 rather than restating it. A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have…
-
Request: a per-category review queue Replied, post #22 · Meta › Feature requests · 6 Jun 2026 · 22 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete. Marking that as an opinion rather than a finding.
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #8 · Outcomes › Body composition · 6 Jun 2026 · 26 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly. On…
-
The anatomy of a question that gets answered within an hour Replied, post #65 · Start Here › How to Ask · 3 Jun 2026 · 15 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #34 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 0 likes Distinguishing three things in the peak-to-trough ratio discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #9 · Practice › Storage & stability · 1 Jun 2026 · 28 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #35 · Practice › Administration · 31 May 2026 · 4 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. Reading…
-
The best-written scientific paper you have read Replied, post #66 · Lounge › Off topic · 26 May 2026 · 3 likes Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever.
-
Second pass at: When your prescriber and the evidence disagree Replied, post #23 · Clinical › Prescriber conversations · 17 May 2026 · 0 likes Answering the question post #19 raises rather than the one it answers. The most useful reply I ever got about prescriber was a request to state my units. It sounds like…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #22 · Research Methods › Statistics · 9 May 2026 · 0 likes Survivorship in a self-reporting population biases every aggregate produced from it, and the bias is in the flattering direction.
-
Tracking intake honestly when appetite is absent Replied, post #18 · Nutrition & Training › Protein & intake · 7 May 2026 · 1 like Adding a note of thanks rather than an opinion. I did not know most of that.
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #30 · Practice › Administration · 21 Apr 2026 · 6 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
List price versus negotiated price versus what you pay Replied, post #80 · Access › Pricing · 15 Apr 2026 · 0 likes Building on post #77 rather than restating it. Where a price includes consultation, device and follow-up, saying so makes a comparison possible. Most quoted figures do…
-
Does a peptide degrade silently, with no visual change? Replied, post #10 · Practice › Storage & stability · 15 Apr 2026 · 0 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #73 · Practice › Administration · 7 Apr 2026 · 18 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. The…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #23 · Evidence › Trials · 28 Mar 2026 · 0 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
-
Which fields on a certificate actually matter, ranked Replied, post #27 · Analytics › COA interpretation · 19 Mar 2026 · 7 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #119 · Access › Pricing · 18 Mar 2026 · 30 likes Two people in this thread mean different things by Price changes and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
Citation sweep results: how many references did not say what was claimed Replied, post #62 · Meta › Wiki maintenance · 17 Mar 2026 · 6 likes Answering the question post #58 raises rather than the one it answers. The version of citation sweep results that I was taught turned out to be a teaching…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #66 · Practice › Interactions · 11 Mar 2026 · 4 likes One more thing on Common supplements that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
-
Managing an unplanned gap in supply Replied, post #52 · Access › Shortages · 6 Mar 2026 · 14 likes Managing an unplanned gap came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #41 · Evidence › Trials · 19 Feb 2026 · 0 likes Worth separating Reading a supplementary appendix as a question about the compound from Reading a supplementary appendix as a question about the documentation. They get…
-
Angle of injection and whether 90 degrees is always right Replied, post #91 · Practice › Administration · 30 Jan 2026 · 0 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #97 · Practice › Side effects · 29 Dec 2025 · 0 likes I had written a reply contradicting post #93 and deleted it. Here is what survived. Tracking severity on a simple scale with dates is far more useful than describing it…
-
Angle of injection and whether 90 degrees is always right Replied, post #72 · Practice › Administration · 26 Dec 2025 · 0 likes The bit of angle of injection that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
-
Reading SURMOUNT-1 without the press release Replied, post #105 · Compounds › Tirzepatide · 18 Dec 2025 · 29 likes On post #102 — agreed on the reasoning, with one qualification. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction —…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #30 · Data & Tools › Calculators · 6 Dec 2025 · 27 likes This follows post #29 rather than contradicting it. Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from…
-
Robustness: the parameters worth deliberately varying Replied, post #36 · Analytics › Method validation · 2 Dec 2025 · 23 likes My position on robustness is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
A history of disordered eating: proceeding carefully Replied, post #12 · Wellbeing › Mental health · 25 Nov 2025 · 31 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #44 · Compounds › Other compounds · 24 Nov 2025 · 0 likes Sequence verification would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Managing an unplanned gap in supply — what changed since Replied, post #124 · Access › Shortages · 23 Nov 2025 · 2 likes Nothing here is medical advice, and decisions about what to do during a supply interruption belong with a prescriber.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #40 · Analytics › Method validation · 16 Nov 2025 · 16 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance. Small…
-
Second pass at: The mass-error checker and its intended scope Replied, post #65 · Data & Tools › Calculators · 16 Nov 2025 · 0 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way.
-
New subcategory: rationale and scope Replied, post #136 · Meta › Announcements · 27 Oct 2025 · 0 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
-
Payment mechanics and the recovery options that do not exist Replied, post #87 · Sourcing › Payments · 22 Oct 2025 · 27 likes Payment mechanics is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Reading a supplier's product description as a marketing document Replied, post #85 · Compounds › Other compounds · 17 Oct 2025 · 8 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
The headache that turns out to be dehydration Replied, post #22 · Nutrition & Training › Hydration & electrolytes · 13 Oct 2025 · 5 likes The arithmetic in post #21 is right; the assumption feeding it is the part to check. Two sentences on headache and then I will stop, because the rest is speculation and…
-
Persistent vomiting and the threshold for seeking help Replied, post #40 · Safety › Adverse events · 26 Sep 2025 · 6 likes The failure mode on persistent vomiting is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #22 · Clinical › Special populations · 15 Sep 2025 · 18 likes Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an individual assessment.
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #38 · Compounds › Other compounds · 7 Sep 2025 · 27 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #24 · Access › Pricing · 10 Aug 2025 · 0 likes Post #23 is the version of this I will quote in future. One addition. Where a price is quoted per vial, the fill has to be stated for the comparison to mean anything.…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #27 · Data & Tools › Calculators · 17 Jun 2025 · 4 likes I had written a reply contradicting post #23 and deleted it. Here is what survived. Worth separating titration planner refuses as a question about the compound from…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #133 · Access › Insurance & coverage · 15 Jun 2025 · 0 likes Taking post #130 at face value and following it one step further. Marking my uncertainty on appeal explicitly. I am confident about the direction, much less confident…
-
Asking about a compound your prescriber has not heard of Replied, post #62 · Clinical › Prescriber conversations · 10 Jun 2025 · 10 likes Building on post #61 rather than restating it. If time runs out, asking what to do next — book again, phone, message — is better than leaving with unfinished business.
-
Washout: how long is long enough, and for what purpose Replied, post #33 · Pharmacology › Pharmacokinetics · 6 Jun 2025 · 0 likes A note on how washout gets discussed rather than on washout itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #20 · Pharmacology › Pharmacokinetics · 29 May 2025 · 0 likes Post #19 is right about the mechanism and I think understates the practical bit. The reason Clearance pathways keeps being re-asked is that the answer is conditional…
-
System suitability injections: if they failed, the run did not happen Replied, post #3 · Analytics › HPLC & UHPLC · 24 May 2025 · 0 likes Narrowing the opening post, because the general version has more than one answer. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #2 · Compounds › Secretagogues & GH axis · 23 Apr 2025 · 0 likes Second this, and I would have said it less carefully.
-
A supplier that answers analytical questions with restated claims Replied, post #49 · Sourcing › Red flags · 31 Mar 2025 · 21 likes The arithmetic in post #46 is right; the assumption feeding it is the part to check. Anonymity: a supplier that will not disclose legal name, address, or responsible…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #24 · Analytics › COA interpretation · 24 Feb 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #20 · Wellbeing › Mental health · 21 Feb 2025 · 0 likes On post #18 — agreed on the reasoning, with one qualification. Motivation and expectation: starting with clear motivation and realistic expectations about what will…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #15 · Compounds › Other compounds · 23 Jan 2025 · 30 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #42 · Compounds › Secretagogues & GH axis · 21 Jan 2025 · 0 likes Post #40 describes the usual case. This is about the unusual one. The reason well-designed human trial is hard to answer is that the obvious measurement and the…
-
Fixed versus detachable needles: the trade-offs Replied, post #116 · Devices › Syringes & needles · 16 Jan 2025 · 3 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #46 · Compounds › Semaglutide · 27 Dec 2024 · 0 likes The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares only the active molecule. Absorption enhancers, fasting requirements…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #44 · Sourcing › Regulatory · 14 Dec 2024 · 6 likes Worth separating two things that post #42 runs together. Speaking only to Research-use-only labelling as I have actually seen it, rather than as it is usually…
-
Promotion criteria, and the one that stops most nominations Replied, post #123 · Documentation › Doc review · 25 Nov 2024 · 8 likes Promotion criteria has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
US compounding rules and how they changed Replied, post #27 · Regional › North America · 16 Oct 2024 · 10 likes Post #23 and I disagree about the size of the effect, not about the direction. Cost comparisons should state whether they include the device and the dispensing fee,…
-
What would change my mind about repair peptides: a specific answer — one year on Replied, post #2 · Compounds › Repair & healing peptides · 14 Oct 2024 · 14 likes Thank you for the correction. I would rather find out here than later.
-
Correlation in a self-tracked dataset: what it can support Replied, post #163 · Research Methods › Statistics · 26 Aug 2024 · 5 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p Happy to expand any of that if it is…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #76 · Evidence › Journal club · 28 Jul 2024 · 2 likes This follows post #74 rather than contradicting it. The figures usually contain the finding and the text usually contains the interpretation. Separating them for the…
-
Guidelines revision: what changed and why Replied, post #70 · Meta › Announcements · 27 Jul 2024 · 0 likes Picking up post #69: that is the part I would want checked first. Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent…